Children’s clinical trial for autism symptoms

The Servier study is for children with autism and is testing a medication called bumetanide.

Please, take a look:

Important update about the Bumetanide Study for Children

Due to popular demand, we are no longer able to include any more children on the Bumetanide Clinical Trial. We have exceeded our target of identifying and including suitable children to participate in the Bumetanide study. We would like to thank everyone for their interest, support and involvement in our children services.

We are pleased to announce that we have several clinical studies for children with Autism or ADHD that are currently in the pipeline. Should you wish to receive any more information about these, please sign up to our Newsletter here to be the first to hear about our latest updates at Re:Cognition Health.

To register your interest please fill out the form below: